Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity

MONDAY, April 10, 2023 -- Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 severity in patients with cirrhosis, according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news